342 related articles for article (PubMed ID: 34805272)
1. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
Galili U
Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
[TBL] [Abstract][Full Text] [Related]
2. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
3. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
Galili U
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933166
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
6. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
7. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U
Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
[TBL] [Abstract][Full Text] [Related]
8. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
9. Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?
Galili U
Glycobiology; 2016 Nov; 26(11):1140-1150. PubMed ID: 27567275
[TBL] [Abstract][Full Text] [Related]
10. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
11. Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections.
Galili U
Antibodies (Basel); 2020 Jun; 9(2):. PubMed ID: 32580274
[TBL] [Abstract][Full Text] [Related]
12. Paleo-immunology of human anti-carbohydrate antibodies preventing primate extinctions.
Galili U
Immunology; 2023 Jan; 168(1):18-29. PubMed ID: 36161654
[TBL] [Abstract][Full Text] [Related]
13. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
Galili U
J Mol Evol; 2015 Jan; 80(1):1-9. PubMed ID: 25315716
[TBL] [Abstract][Full Text] [Related]
14. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
15. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
[TBL] [Abstract][Full Text] [Related]
18. Avoiding detrimental human immune response against Mammalian extracellular matrix implants.
Galili U
Tissue Eng Part B Rev; 2015 Apr; 21(2):231-41. PubMed ID: 25315097
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.
Galili U
J Immunol Res; 2015; 2015():589648. PubMed ID: 25922849
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris.
Chen ZC; Tanemura M; Galili U
Glycobiology; 2001 Jul; 11(7):577-86. PubMed ID: 11447137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]